Cargando…

Further Increase of Vancomycin-Resistant Enterococcus faecium, Amikacin- and Fluoroquinolone-Resistant Klebsiella pneumoniae, and Imipenem-Resistant Acinetobacter spp. in Korea: 2003 KONSAR Surveillance

Monitoring temporal trends of antimicrobial resistance can provide useful information for the empirical selection of antimicrobial agents to treat infected patients and for the control of nosocomial infections. In this study, we analyzed antimicrobial resistance of clinically relevant bacteria in 20...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Kyungwon, Park, Ki Hyung, Jeong, Seok Hoon, Lim, Hwan Sub, Shin, Jong Hee, Yong, Dongeun, Ha, Gyoung-Yim, Chong, Yunsop
Formato: Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687580/
https://www.ncbi.nlm.nih.gov/pubmed/16502484
http://dx.doi.org/10.3349/ymj.2006.47.1.43
_version_ 1782167546127974400
author Lee, Kyungwon
Park, Ki Hyung
Jeong, Seok Hoon
Lim, Hwan Sub
Shin, Jong Hee
Yong, Dongeun
Ha, Gyoung-Yim
Chong, Yunsop
author_facet Lee, Kyungwon
Park, Ki Hyung
Jeong, Seok Hoon
Lim, Hwan Sub
Shin, Jong Hee
Yong, Dongeun
Ha, Gyoung-Yim
Chong, Yunsop
author_sort Lee, Kyungwon
collection PubMed
description Monitoring temporal trends of antimicrobial resistance can provide useful information for the empirical selection of antimicrobial agents to treat infected patients and for the control of nosocomial infections. In this study, we analyzed antimicrobial resistance of clinically relevant bacteria in 2003 at Korean hospitals and at a commercial laboratory. The following organism-antimicrobial agent resistance combinations were very prevalent: oxacillin-resistant Staphylococcus aureus (68%), expanded-spectrum cephalosporin-resistant Klebsiella pneumoniae (25%), and fluoroquinolone-resistant Escherichia coli (33%), Acinetobacter spp. (58%), and Pseudomonas aeruginosa (40%). Moreover, gradual increases in vancomycin-resistant Enterococcus faecium (20%), cefoxitin-resistant E. coli (10%) and K. pneumoniae (23%), and imipenem-resistant P. aeruginosa (20%) and Acinetobacter spp. (13%) were also observed. The resistance rates of Acinetobacter spp. to most antimicrobial agents at hospitals and at the commercial laboratory were similar. Among the Acinetobacter spp. isolated at a tertiary-care hospital, 46.2% were multidrug-resistant to 9-12 of 13 antimicrobial agents, and 18.3% were panresistant. The exclusion of duplicate isolates at a tertiary-care hospital significantly lowered the proportion of oxacillin-resistant S. aureus, vancomycin-resistant E. faecium, and fluoroquinolone-resistant E. coli.
format Text
id pubmed-2687580
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher Yonsei University College of Medicine
record_format MEDLINE/PubMed
spelling pubmed-26875802009-06-04 Further Increase of Vancomycin-Resistant Enterococcus faecium, Amikacin- and Fluoroquinolone-Resistant Klebsiella pneumoniae, and Imipenem-Resistant Acinetobacter spp. in Korea: 2003 KONSAR Surveillance Lee, Kyungwon Park, Ki Hyung Jeong, Seok Hoon Lim, Hwan Sub Shin, Jong Hee Yong, Dongeun Ha, Gyoung-Yim Chong, Yunsop Yonsei Med J Original Article Monitoring temporal trends of antimicrobial resistance can provide useful information for the empirical selection of antimicrobial agents to treat infected patients and for the control of nosocomial infections. In this study, we analyzed antimicrobial resistance of clinically relevant bacteria in 2003 at Korean hospitals and at a commercial laboratory. The following organism-antimicrobial agent resistance combinations were very prevalent: oxacillin-resistant Staphylococcus aureus (68%), expanded-spectrum cephalosporin-resistant Klebsiella pneumoniae (25%), and fluoroquinolone-resistant Escherichia coli (33%), Acinetobacter spp. (58%), and Pseudomonas aeruginosa (40%). Moreover, gradual increases in vancomycin-resistant Enterococcus faecium (20%), cefoxitin-resistant E. coli (10%) and K. pneumoniae (23%), and imipenem-resistant P. aeruginosa (20%) and Acinetobacter spp. (13%) were also observed. The resistance rates of Acinetobacter spp. to most antimicrobial agents at hospitals and at the commercial laboratory were similar. Among the Acinetobacter spp. isolated at a tertiary-care hospital, 46.2% were multidrug-resistant to 9-12 of 13 antimicrobial agents, and 18.3% were panresistant. The exclusion of duplicate isolates at a tertiary-care hospital significantly lowered the proportion of oxacillin-resistant S. aureus, vancomycin-resistant E. faecium, and fluoroquinolone-resistant E. coli. Yonsei University College of Medicine 2006-02-28 2006-02-28 /pmc/articles/PMC2687580/ /pubmed/16502484 http://dx.doi.org/10.3349/ymj.2006.47.1.43 Text en Copyright © 2006 The Yonsei University College of Medicine http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Lee, Kyungwon
Park, Ki Hyung
Jeong, Seok Hoon
Lim, Hwan Sub
Shin, Jong Hee
Yong, Dongeun
Ha, Gyoung-Yim
Chong, Yunsop
Further Increase of Vancomycin-Resistant Enterococcus faecium, Amikacin- and Fluoroquinolone-Resistant Klebsiella pneumoniae, and Imipenem-Resistant Acinetobacter spp. in Korea: 2003 KONSAR Surveillance
title Further Increase of Vancomycin-Resistant Enterococcus faecium, Amikacin- and Fluoroquinolone-Resistant Klebsiella pneumoniae, and Imipenem-Resistant Acinetobacter spp. in Korea: 2003 KONSAR Surveillance
title_full Further Increase of Vancomycin-Resistant Enterococcus faecium, Amikacin- and Fluoroquinolone-Resistant Klebsiella pneumoniae, and Imipenem-Resistant Acinetobacter spp. in Korea: 2003 KONSAR Surveillance
title_fullStr Further Increase of Vancomycin-Resistant Enterococcus faecium, Amikacin- and Fluoroquinolone-Resistant Klebsiella pneumoniae, and Imipenem-Resistant Acinetobacter spp. in Korea: 2003 KONSAR Surveillance
title_full_unstemmed Further Increase of Vancomycin-Resistant Enterococcus faecium, Amikacin- and Fluoroquinolone-Resistant Klebsiella pneumoniae, and Imipenem-Resistant Acinetobacter spp. in Korea: 2003 KONSAR Surveillance
title_short Further Increase of Vancomycin-Resistant Enterococcus faecium, Amikacin- and Fluoroquinolone-Resistant Klebsiella pneumoniae, and Imipenem-Resistant Acinetobacter spp. in Korea: 2003 KONSAR Surveillance
title_sort further increase of vancomycin-resistant enterococcus faecium, amikacin- and fluoroquinolone-resistant klebsiella pneumoniae, and imipenem-resistant acinetobacter spp. in korea: 2003 konsar surveillance
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687580/
https://www.ncbi.nlm.nih.gov/pubmed/16502484
http://dx.doi.org/10.3349/ymj.2006.47.1.43
work_keys_str_mv AT leekyungwon furtherincreaseofvancomycinresistantenterococcusfaeciumamikacinandfluoroquinoloneresistantklebsiellapneumoniaeandimipenemresistantacinetobactersppinkorea2003konsarsurveillance
AT parkkihyung furtherincreaseofvancomycinresistantenterococcusfaeciumamikacinandfluoroquinoloneresistantklebsiellapneumoniaeandimipenemresistantacinetobactersppinkorea2003konsarsurveillance
AT jeongseokhoon furtherincreaseofvancomycinresistantenterococcusfaeciumamikacinandfluoroquinoloneresistantklebsiellapneumoniaeandimipenemresistantacinetobactersppinkorea2003konsarsurveillance
AT limhwansub furtherincreaseofvancomycinresistantenterococcusfaeciumamikacinandfluoroquinoloneresistantklebsiellapneumoniaeandimipenemresistantacinetobactersppinkorea2003konsarsurveillance
AT shinjonghee furtherincreaseofvancomycinresistantenterococcusfaeciumamikacinandfluoroquinoloneresistantklebsiellapneumoniaeandimipenemresistantacinetobactersppinkorea2003konsarsurveillance
AT yongdongeun furtherincreaseofvancomycinresistantenterococcusfaeciumamikacinandfluoroquinoloneresistantklebsiellapneumoniaeandimipenemresistantacinetobactersppinkorea2003konsarsurveillance
AT hagyoungyim furtherincreaseofvancomycinresistantenterococcusfaeciumamikacinandfluoroquinoloneresistantklebsiellapneumoniaeandimipenemresistantacinetobactersppinkorea2003konsarsurveillance
AT chongyunsop furtherincreaseofvancomycinresistantenterococcusfaeciumamikacinandfluoroquinoloneresistantklebsiellapneumoniaeandimipenemresistantacinetobactersppinkorea2003konsarsurveillance
AT furtherincreaseofvancomycinresistantenterococcusfaeciumamikacinandfluoroquinoloneresistantklebsiellapneumoniaeandimipenemresistantacinetobactersppinkorea2003konsarsurveillance